High cholesterol diet results in increased expression of interleukin-6 and caspase-1 in the brain of apolipoprotein E knockout and wild type mice

Inflammation in the central nervous system is an early hallmark of many neurodegenerative diseases including Alzheimer's disease (AD). Recently, increasing evidence suggests that hypercholesterolemia during midlife and abnormalities in the cholesterol metabolism could have an important role in the pathogenesis of AD. In the present study, we have evaluated the effect of high cholesterol (HC) diet on the expression of interleukin-6 (IL-6), a cytokine involved in neurodegeneration, and caspase-1, that is responsible for the cleavage of the precursors of interleukin-1 beta (IL-1 beta) and interleukin-18 (IL-18) in the brain of apolipoprotein E (Apo E) knock-out (KO) and wild type (WT) mice. The density of IL-6-positive cells was increased in the hippocampus (p<0.0001) and the dorsal part of the cortex (p<0.001) of KO and WT mice on HC diet (KOHC and WTHC mice, respectively) compared to KO and WT mice on ND (KOND and WTND mice, respectively). KOHC mice had increased caspase-1 positive cells and staining intensity in the hippocampus in comparison with WTHC mice (p<0.01). In the hippocampus, the density of caspase-1 positive cells was also higher in KOHC compared to KOND mice (p<0.05) and KOHC compared with WTHC mice (p<0.01). There was a major increase in caspase-1 immunoreactivity and cell density in both the dosal part of the cortex (p<0.001) and the lateral part of the cortex (p<0.005) in KO and WT mice on HC diet compared to ND. The findings of the present study indicate that chronic exposure to HC diet increases the expression of the two important inflammatory mediators IL-6 and caspase-1 in the brain of KO and WT mice. In the case of caspase-1, we report a major difference in the effect of HC diet on the KO mice compared to WT mice in the hippocampus. Increased expression of inflammatory mediators involved in neurodegeneration could be a potential mechanism by which hypercholesterolemia and HC diet increase the risk of AD.

[1]  W. Griffin,et al.  Interleukin-1 Promotes Expression and Phosphorylation of Neurofilament and tau Proteins in Vivo , 2000, Experimental Neurology.

[2]  K. Blennow,et al.  Intrathecal inflammation precedes development of Alzheimer’s disease , 2003, Journal of neurology, neurosurgery, and psychiatry.

[3]  E. Keller,et al.  Age-associated increased interleukin-6 gene expression, late-life diseases, and frailty. , 2000, Annual review of medicine.

[4]  A. Hofman,et al.  Pharmacologic agents associated with a preventive effect on Alzheimer's disease: a review of the epidemiologic evidence. , 2002, Epidemiologic reviews.

[5]  J. Dietschy,et al.  Cholesterol metabolism in the brain , 2001, Current opinion in lipidology.

[6]  N. Maeda,et al.  Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E. , 1992, Science.

[7]  Hee-Yong Kim,et al.  A new role for apolipoprotein E: modulating transport of polyunsaturated phospholipid molecular species in synaptic plasma membranes , 2002, Journal of neurochemistry.

[8]  George Paxinos,et al.  The Mouse Brain in Stereotaxic Coordinates , 2001 .

[9]  John Calvin Reed,et al.  Fundamental role of the Rip2/caspase-1 pathway in hypoxia and ischemia-induced neuronal cell death , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[10]  S. Barger,et al.  Neuronal–Glial Interactions Mediated by Interleukin-1 Enhance Neuronal Acetylcholinesterase Activity and mRNA Expression , 2000, The Journal of Neuroscience.

[11]  B. Winblad,et al.  Effects of high cholesterol diet on gliosis in apolipoprotein E knockout mice Implications for Alzheimer’s disease and stroke , 2004, Neuroscience Letters.

[12]  G. Stoll,et al.  Induction of the proinflammatory cytokine interleukin‐18 by axonal injury , 2001, Journal of neuroscience research.

[13]  H. Cohen,et al.  Cytokines and Cognition—The Case for A Head‐to‐Toe Inflammatory Paradigm , 2002, Journal of the American Geriatrics Society.

[14]  C. Colton,et al.  Apolipoprotein E isoform mediated regulation of nitric oxide release. , 2002, Free radical biology & medicine.

[15]  B. Winblad,et al.  Neuronal expression of caspase-1 immunoreactivity in the rat central nervous system , 2004, Journal of Neuroimmunology.

[16]  C. Kawas,et al.  Immune reactive cells in senile plaques and cognitive decline in Alzheimer’s disease , 2003, Neurobiology of Aging.

[17]  A. Hofman,et al.  Nonsteroidal antiinflammatory drugs and the risk of Alzheimer's disease. , 2001, The New England journal of medicine.

[18]  J. Losy,et al.  IL‐18 in patients with multiple sclerosis , 2001, Acta neurologica Scandinavica.

[19]  G. Forloni,et al.  Expression of amyloid precursor protein mRNAs in endothelial, neuronal and glial cells: modulation by interleukin-1. , 1992, Brain research. Molecular brain research.

[20]  T. Kishimoto,et al.  Gp130 and the interleukin-6 family of cytokines. , 1997, Annual review of immunology.

[21]  J W Rowe,et al.  Interleukin-6 and risk of cognitive decline: MacArthur Studies of Successful Aging , 2002, Neurology.

[22]  R. Black,et al.  Generation of biologically active interleukin-1 beta by proteolytic cleavage of the inactive precursor. , 1988, The Journal of biological chemistry.

[23]  B. Winblad,et al.  Statins in the Prevention and Treatment of Alzheimer Disease , 2002, Alzheimer disease and associated disorders.

[24]  R. Dantzer,et al.  Effects of lipopolysaccharide and glucocorticoids on expression of interleukin-1β converting enzyme in the pituitary and brain of mice , 1996, Journal of Neuroimmunology.

[25]  B. Winblad,et al.  Immunohistochemical localization of interleukin-1β, interleukin-1 receptor antagonist and interleukin-1β converting enzyme/caspase-1 in the rat brain after peripheral administration of kainic acid , 1999, Neuroscience.

[26]  C. Masters,et al.  In‐vitro matured human macrophages express Alzheimer's βA4‐amyloid precursor protein indicating synthesis in microglial cells , 1991, FEBS letters.

[27]  Rong Wang,et al.  Hypercholesterolemia Accelerates the Alzheimer's Amyloid Pathology in a Transgenic Mouse Model , 2000, Neurobiology of Disease.

[28]  G. Forloni,et al.  Reciprocal control of inflammatory cytokines, IL-1 and IL-6, and β-amyloid production in cultures , 1995, Neuroscience Letters.

[29]  Rodney W. Johnson,et al.  Increased interleukin-6 expression by microglia from brain of aged mice , 1999, Journal of Neuroimmunology.

[30]  Shai Shaham,et al.  The C. elegans cell death gene ced-3 encodes a protein similar to mammalian interleukin-1β-converting enzyme , 1993, Cell.

[31]  K. Iverfeldt,et al.  Early induction of interleukin-6 mRNA in the hippocampus and cortex of APPsw transgenic mice Tg2576 , 2001, Neuroscience Letters.

[32]  P. Mcgeer,et al.  Clinically tested drugs for Alzheimer’s disease , 2003, Expert opinion on investigational drugs.

[33]  J. Mankovich,et al.  Crystal structure of the cysteine protease interleukin-1β-converting enzyme: A (p20/p10)2 homodimer , 1994, Cell.

[34]  D. Sparks,et al.  Alterations of Alzheimer's Disease in the Cholesterol‐fed Rabbit, Including Vascular Inflammation: Preliminary Observations , 2000, Annals of the New York Academy of Sciences.

[35]  J Tuomilehto,et al.  Midlife vascular risk factors and Alzheimer's disease in later life: longitudinal, population based study , 2001, BMJ.

[36]  Junying Yuan,et al.  Induction of apoptosis in fibroblasts by IL-1β-converting enzyme, a mammalian homolog of the C. elegans cell death gene ced-3 , 1993, Cell.

[37]  C. Dinarello,et al.  Elevated Intracranial IL-18 in Humans and Mice after Traumatic Brain Injury and Evidence of Neuroprotective Effects of IL-18—Binding Protein after Experimental Closed Head Injury , 2002, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[38]  M. Hüll,et al.  Interleukin-6-associated inflammatory processes in Alzheimer's disease: New therapeutic options , 1996, Neurobiology of Aging.

[39]  R. Maccioni,et al.  Interleukin-6 induces Alzheimer-type phosphorylation of tau protein by deregulating the cdk5/p35 pathway. , 2004, Experimental cell research.

[40]  G. Fantuzzi,et al.  Response to local inflammation of IL-1 beta-converting enzyme- deficient mice. , 1997, Journal of immunology.

[41]  D. Gruol,et al.  Physiological and pathological roles of interleukin-6 in the central nervous system , 1997, Molecular Neurobiology.

[42]  P. Contreras,et al.  Increased Expression of IL-1β Converting Enzyme in Hippocampus after Ischemia: Selective Localization in Microglia , 1996, The Journal of Neuroscience.

[43]  Guo-Yuan Yang,et al.  Reduced Ischemic Brain Injury in Interleukin-1β Converting Enzyme—Deficient Mice , 1998, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[44]  H. W. Harris,et al.  Interleukin 1 regulates synthesis of amyloid beta-protein precursor mRNA in human endothelial cells. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[45]  T. Golde Inflammation takes on Alzheimer disease , 2002, Nature Medicine.

[46]  M. Hüll Interleukin-6-Associated Inflammatory Processes in Alzheimer's Disease: New Therapeutic Options , 1996 .

[47]  M. Kurimoto,et al.  Interferon-γ–inducing factor (IL-18) and interferon-γ in inflammatory CNS diseases , 1999, Neurology.

[48]  D. Steinberg,et al.  The cholesterol controversy is over. Why did it take so long? , 1989, Circulation.

[49]  Richard Mohs,et al.  Caspase gene expression in the brain as a function of the clinical progression of Alzheimer disease. , 2003, Archives of neurology.

[50]  P. Cameron,et al.  Identification of a monocyte specific pre-interleukin 1 beta convertase activity. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[51]  R. Mrak,et al.  Interleukin‐1 in the genesis and progression of and risk for development of neuronal degeneration in Alzheimer’s disease , 2002, Journal of leukocyte biology.

[52]  Mark A. Murcko,et al.  Structure and mechanism of interleukin-lβ converting enzyme , 1994, Nature.

[53]  N. Maeda,et al.  Diet-induced atherosclerosis in mice heterozygous and homozygous for apolipoprotein E gene disruption. , 1994, The Journal of clinical investigation.

[54]  C. March,et al.  Molecular cloning of the interleukin-1 beta converting enzyme. , 1992, Science.